Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 11.77 M10.88 M9.26 M10.09 M10.81 M9.41 M 39.57 M Research & development —————— — Operating income 14.4 M14.88 M6.89 M12.72 M8.02 M19.26 M 46.89 M Non-Operating Income, Total -14.32 M-15.21 M-14.59 M-14.76 M-14.26 M-14.74 M -58.34 M Interest expense, net of interest capitalized 14.11 M14.61 M14.61 M14.46 M13.96 M14.49 M 57.52 M Non-Operating Income, excl. Interest Expenses -14.32 M-15.22 M-14.59 M-14.77 M-14.26 M-14.75 M -58.38 M Unusual income/expense -2 00018 K3 00014 K1 00015 K 33 K Pretax income 84 K-323 K-7.7 M-2.04 M-6.24 M4.52 M -11.45 M Equity in earnings -209 K-616 K20 K-311 K-301 K-260 K -852 K Taxes 1.12 M2.08 M715 K856 K518 K1.88 M 3.96 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -1.03 M-2.41 M-8.41 M-2.89 M-6.76 M2.65 M -15.42 M Discontinued operations —————— — Net income -1.03 M-2.41 M-8.41 M-2.89 M-6.76 M2.65 M -15.42 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -1.03 M-2.41 M-8.41 M-2.89 M-6.76 M2.65 M -15.42 M Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) —————— — Average basic shares outstanding —————— — Diluted shares outstanding —————— — EBITDA 26.74 M26.91 M18.84 M24.57 M20.56 M27.66 M 91.62 M EBIT 13.92 M14.27 M6.5 M12.17 M7.69 M14.61 M 40.96 M Cost of revenue 89.58 M78.5 M75.74 M74.8 M89.5 M107.59 M 347.63 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 12.82 M12.64 M12.34 M12.41 M12.87 M13.05 M 50.67 M